Cargando…

Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance

BACKGROUND: Diets emphasizing unsaturated fat and high fiber are associated with reducing cardiometabolic risk factors. Avocados are rich in MUFA and PUFA fats and fiber. OBJECTIVES: Assess replacement of carbohydrate energy with avocado energy for 12 wk on glucose homeostasis and cardiometabolic ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuhuiqun, Xiao, Di, Guzman, Gabriela, Edirisinghe, Indika, Burton-Freeman, Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486596/
https://www.ncbi.nlm.nih.gov/pubmed/35700149
http://dx.doi.org/10.1093/jn/nxac126
_version_ 1784792317785276416
author Zhang, Xuhuiqun
Xiao, Di
Guzman, Gabriela
Edirisinghe, Indika
Burton-Freeman, Britt
author_facet Zhang, Xuhuiqun
Xiao, Di
Guzman, Gabriela
Edirisinghe, Indika
Burton-Freeman, Britt
author_sort Zhang, Xuhuiqun
collection PubMed
description BACKGROUND: Diets emphasizing unsaturated fat and high fiber are associated with reducing cardiometabolic risk factors. Avocados are rich in MUFA and PUFA fats and fiber. OBJECTIVES: Assess replacement of carbohydrate energy with avocado energy for 12 wk on glucose homeostasis and cardiometabolic risk factors in self-selecting free-living adults who are overweight or with obesity and have insulin resistance. METHODS: In a single-center, randomized, 2-arm, controlled, 12-wk parallel trial, adults [n = 93; male/female: 39/54; mean ± SD age: 42 ± 12 y; BMI: 32.6 ± 3.9 (in kg/m(2));  HOMA-IR: 2.7 ± 1.7] were counseled to exchange avocado (AV) or control food (C; low fat, low fiber, energy matched) for carbohydrate food in their usual diet for 12 wk. The primary outcome was the change in Matsuda Insulin Sensitivity Index (MISI) after 12-wk interventions. Secondary outcomes were changes in fasting and post–oral glucose tolerance test glycemic variables, fasting lipids, endothelial activation and inflammation markers. Automated Self-Administered 24-h Dietary Assessment Tool captured weekly dietary intake. Intervention effects were mainly determined by ANCOVA using PC-SAS version 9.4. RESULTS: Dietary total, MUFA, and PUFA fat; fiber; and vegetable intake were higher in the AV group compared with the C group (P < 0.05), and no change in body weight or composition was observed (P > 0.05). Differences between the changes in MISI after AV compared with C were not different (Δ0–12 wk, P = 0.1092). Differences in fasting insulin (Δ0–12 wk, P = 0.0855) and improved glycated hemoglobin (Δ0–12 wk, P = 0.0632) after AV compared with C were suggested. C-reactive protein was significantly lower after AV compared with C at 12 wk (P = 0.0418). Select biomarkers of endothelial activation and lipoproteins by NMR were also influenced by AV compared with C food intake. CONCLUSIONS: Avocado intake was associated with a healthier dietary pattern and trends favoring improved glucose control and reduced biomarkers of cardiometabolic risk when replacing avocado energy for carbohydrate energy in free-living adults who are overweight or with obesity and have insulin resistance. This trial was registered at clinicaltrials.gov as NCT 02695433.
format Online
Article
Text
id pubmed-9486596
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-94865962022-09-21 Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance Zhang, Xuhuiqun Xiao, Di Guzman, Gabriela Edirisinghe, Indika Burton-Freeman, Britt J Nutr Nutrition and Disease BACKGROUND: Diets emphasizing unsaturated fat and high fiber are associated with reducing cardiometabolic risk factors. Avocados are rich in MUFA and PUFA fats and fiber. OBJECTIVES: Assess replacement of carbohydrate energy with avocado energy for 12 wk on glucose homeostasis and cardiometabolic risk factors in self-selecting free-living adults who are overweight or with obesity and have insulin resistance. METHODS: In a single-center, randomized, 2-arm, controlled, 12-wk parallel trial, adults [n = 93; male/female: 39/54; mean ± SD age: 42 ± 12 y; BMI: 32.6 ± 3.9 (in kg/m(2));  HOMA-IR: 2.7 ± 1.7] were counseled to exchange avocado (AV) or control food (C; low fat, low fiber, energy matched) for carbohydrate food in their usual diet for 12 wk. The primary outcome was the change in Matsuda Insulin Sensitivity Index (MISI) after 12-wk interventions. Secondary outcomes were changes in fasting and post–oral glucose tolerance test glycemic variables, fasting lipids, endothelial activation and inflammation markers. Automated Self-Administered 24-h Dietary Assessment Tool captured weekly dietary intake. Intervention effects were mainly determined by ANCOVA using PC-SAS version 9.4. RESULTS: Dietary total, MUFA, and PUFA fat; fiber; and vegetable intake were higher in the AV group compared with the C group (P < 0.05), and no change in body weight or composition was observed (P > 0.05). Differences between the changes in MISI after AV compared with C were not different (Δ0–12 wk, P = 0.1092). Differences in fasting insulin (Δ0–12 wk, P = 0.0855) and improved glycated hemoglobin (Δ0–12 wk, P = 0.0632) after AV compared with C were suggested. C-reactive protein was significantly lower after AV compared with C at 12 wk (P = 0.0418). Select biomarkers of endothelial activation and lipoproteins by NMR were also influenced by AV compared with C food intake. CONCLUSIONS: Avocado intake was associated with a healthier dietary pattern and trends favoring improved glucose control and reduced biomarkers of cardiometabolic risk when replacing avocado energy for carbohydrate energy in free-living adults who are overweight or with obesity and have insulin resistance. This trial was registered at clinicaltrials.gov as NCT 02695433. Oxford University Press 2022-06-14 /pmc/articles/PMC9486596/ /pubmed/35700149 http://dx.doi.org/10.1093/jn/nxac126 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Nutrition and Disease
Zhang, Xuhuiqun
Xiao, Di
Guzman, Gabriela
Edirisinghe, Indika
Burton-Freeman, Britt
Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
title Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
title_full Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
title_fullStr Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
title_full_unstemmed Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
title_short Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
title_sort avocado consumption for 12 weeks and cardiometabolic risk factors: a randomized controlled trial in adults with overweight or obesity and insulin resistance
topic Nutrition and Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486596/
https://www.ncbi.nlm.nih.gov/pubmed/35700149
http://dx.doi.org/10.1093/jn/nxac126
work_keys_str_mv AT zhangxuhuiqun avocadoconsumptionfor12weeksandcardiometabolicriskfactorsarandomizedcontrolledtrialinadultswithoverweightorobesityandinsulinresistance
AT xiaodi avocadoconsumptionfor12weeksandcardiometabolicriskfactorsarandomizedcontrolledtrialinadultswithoverweightorobesityandinsulinresistance
AT guzmangabriela avocadoconsumptionfor12weeksandcardiometabolicriskfactorsarandomizedcontrolledtrialinadultswithoverweightorobesityandinsulinresistance
AT edirisingheindika avocadoconsumptionfor12weeksandcardiometabolicriskfactorsarandomizedcontrolledtrialinadultswithoverweightorobesityandinsulinresistance
AT burtonfreemanbritt avocadoconsumptionfor12weeksandcardiometabolicriskfactorsarandomizedcontrolledtrialinadultswithoverweightorobesityandinsulinresistance